The Journal of Experimental Medicine
PBL InterferonSource
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 26 June 2000.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 544K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, B.-S.
Right arrow Articles by Jung, J. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, B.-S.
Right arrow Articles by Jung, J. U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2000/7/11/ $5.00
The Journal of Experimental Medicine, Volume 192, Number 1, July 3, 2000 11-22


Original Article

Inhibition of Intracellular Transport of B Cell Antigen Receptor Complexes by Kaposi's Sarcoma–associated Herpesvirus K1

Bok-Soo Leea, Xavier Alvarezb, Satoshi Ishidoa, Andrew A. Lacknerb, and Jae U. Junga
a Department of Microbiology and Molecular Genetics, New England Regional Primate Research Center, Harvard Medical School, Southborough, Massachusetts 01772
b Department of Pathology, New England Regional Primate Research Center, Harvard Medical School, Southborough, Massachusetts 01772

Correspondence to: Jae U. Jung, Tumor Virology Division, New England Regional Primate Research Center, Harvard Medical School, 1 Pine Hill Dr., Southborough, MA 01772. Tel:508-624-8083 Fax:508-786-1416 E-mail:jae_jung{at}hms.harvard.edu.

The B cell antigen receptor (BCR) is a large complex that consists of a disulfide-linked tetramer of two transmembrane heavy (µ) chains and two light ({lambda} or {kappa}) chains in association with a heterodimer of Ig{alpha} and Igß. Kaposi's sarcoma–associated herpesvirus (KSHV) encodes a transforming protein called K1, which has structural and functional similarity to Ig{alpha} and Igß. We demonstrate that K1 downregulates the expression of BCR complexes on the surface. The NH2-terminal region of K1 specifically interacts with the µ chains of BCR complexes, and this interaction retains BCR complexes in the endoplasmic reticulum, preventing their intracellular transport to the cell surface. Thus, KSHV K1 resembles Ig{alpha} and Igß in its ability to induce signaling and to interact with µ chains of the BCR. However, unlike Ig{alpha} and Igß, which interact with µ chains to direct BCR complexes to the cell surface, K1 interacts with µ chains to block the intracellular transport of BCR complexes to the cell surface. These results demonstrate a unique feature of the K1 transforming protein, which may confer virus-infected cells with a long-term survival advantage.

Key Words: Kaposi's sarcoma–associated herpesvirus, K1, B cell antigen receptor, downregulation, intracellular transport


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS